SSH - QUAD CITIES INC. — History
CCN 162001 | 3-year financial timeline | COVID resilience: 30/100
🛡️ Public data only — no PHI permitted on this instance.
$14M
Latest Revenue (FY2022)
-2.3%
Revenue CAGR (3yr)
-14.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $15M | $14M | -6.5% | -2.3% |
| Operating Expenses | $14M | $16M | $16M | +2.3% | +6.0% |
| Operating Margin | 2.9% | -4.5% | -14.4% | -216.6% | +0.0% |
| Net Income | $0M | $-1M | $-2M | -195.9% | +0.0% |
| Licensed Beds | 50 | 50 | 50 | +0.0% | +0.0% |
| Total Patient Days | 8,489 | 8,138 | 7,103 | -12.7% | -8.5% |
| Medicare Day % | 68% | 61% | 67% | +9.0% | -1.2% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 30/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -4.6% ($15M → $14M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-2.3%
This Hospital
+7.6%
State Avg
Latest Margin
-14.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $14M | -23.0% |
| FY2024 (proj) | $13M | -31.6% |
| FY2025 (proj) | $13M | -40.3% |